Literature DB >> 21718815

Identification and characterization of the major alternative promoter regulating Bcrp1/Abcg2 expression in the mouse intestine.

Karthika Natarajan1, Yi Xie, Takeo Nakanishi, William T Beck, Kenneth S Bauer, Douglas D Ross.   

Abstract

Mouse models are often used to predict drug absorption in humans. Mouse Bcrp1 protein exhibits sequence and functional homology with human BCRP protein. Additionally, BCRP/Bcrp1 expression is regulated by alternative promoter usage in humans and mice; however, the precise intestine-specific alternative promoter utilized in either species is yet to be determined. Therefore we sought to identify and characterize the mouse intestinal Bcrp1 promoter. Using real-time quantitative RT-PCR and 5' RACE PCR we first established the predominance of a single Bcrp1 first exon (E1b) in the Bcrp1 mRNA isolated throughout the mouse intestine. Simultaneously using 5' RACE PCR we identified E1C as the predominant BCRP 5' UTR expressed in the human intestine. Next we established functional activity for the murine promoter upstream of E1b using reporter assays. Subsequently using deletion-construct analysis we found the core promoter region to span -231 to -42bps from the transcriptional start site of E1b. We then predicted a cAMP response element (CRE) as a transcription factor binding site unique only to the E1b promoter region, using in silico methods. We finally established functional interaction of phospho-CREB (p-CREB) protein with the CRE on the E1b promoter using both functional assays and chromatin immunoprecipitation assays. In conclusion, mouse intestinal Bcrp1 expression is regulated by a single alternative promoter upstream of E1b, the predominant Bcrp1 mRNA isoform expressed in the mouse intestine. Furthermore, Bcrp1 E1b mRNA expression is regulated by binding of p-CREB to its cis site on the mouse E1b promoter region. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21718815      PMCID: PMC3148308          DOI: 10.1016/j.bbagrm.2011.06.004

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  33 in total

1.  Interaction of the breast cancer resistance protein with plant polyphenols.

Authors:  Hiran C Cooray; Tavan Janvilisri; Hendrik W van Veen; Stephen B Hladky; Margery A Barrand
Journal:  Biochem Biophys Res Commun       Date:  2004-04-23       Impact factor: 3.575

2.  A multidrug resistance transporter from human MCF-7 breast cancer cells.

Authors:  L A Doyle; W Yang; L V Abruzzo; T Krogmann; Y Gao; A K Rishi; D D Ross
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

3.  Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes.

Authors:  K Miyake; L Mickley; T Litman; Z Zhan; R Robey; B Cristensen; M Brangi; L Greenberger; M Dean; T Fojo; S E Bates
Journal:  Cancer Res       Date:  1999-01-01       Impact factor: 12.701

Review 4.  Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.

Authors:  S F Altschul; T L Madden; A A Schäffer; J Zhang; Z Zhang; W Miller; D J Lipman
Journal:  Nucleic Acids Res       Date:  1997-09-01       Impact factor: 16.971

5.  Predicting Pol II promoter sequences using transcription factor binding sites.

Authors:  D S Prestridge
Journal:  J Mol Biol       Date:  1995-06-23       Impact factor: 5.469

6.  The influence of primary and secondary DNA structure in deletion and duplication between direct repeats in Escherichia coli.

Authors:  T Q Trinh; R R Sinden
Journal:  Genetics       Date:  1993-06       Impact factor: 4.562

7.  The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria.

Authors:  Johan W Jonker; Marije Buitelaar; Els Wagenaar; Martin A Van Der Valk; George L Scheffer; Rik J Scheper; Torsten Plosch; Folkert Kuipers; Ronald P J Oude Elferink; Hilde Rosing; Jos H Beijnen; Alfred H Schinkel
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-12       Impact factor: 11.205

8.  A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance.

Authors:  R Allikmets; L M Schriml; A Hutchinson; V Romano-Spica; M Dean
Journal:  Cancer Res       Date:  1998-12-01       Impact factor: 12.701

9.  Increased oral bioavailability of topotecan in combination with the breast cancer resistance protein and P-glycoprotein inhibitor GF120918.

Authors:  C M F Kruijtzer; J H Beijnen; H Rosing; W W ten Bokkel Huinink; M Schot; R C Jewell; E M Paul; J H M Schellens
Journal:  J Clin Oncol       Date:  2002-07-01       Impact factor: 44.544

10.  Establishment of conditionally immortalized epithelial cell lines from both colon and small intestine of adult H-2Kb-tsA58 transgenic mice.

Authors:  R H Whitehead; P E VanEeden; M D Noble; P Ataliotis; P S Jat
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-15       Impact factor: 11.205

View more
  10 in total

1.  Targeting the ABCG2-overexpressing multidrug resistant (MDR) cancer cells by PPARγ agonists.

Authors:  Kenneth K W To; Brian Tomlinson
Journal:  Br J Pharmacol       Date:  2013-11       Impact factor: 8.739

2.  Breast Cancer Resistance Protein and Multidrug Resistance Protein 2 Regulate the Disposition of Acacetin Glucuronides.

Authors:  Huangyu Jiang; Jia Yu; Haihui Zheng; Jiamei Chen; Jinjun Wu; Xiaoxiao Qi; Ying Wang; Xinchun Wang; Ming Hu; Lijun Zhu; Zhongqiu Liu
Journal:  Pharm Res       Date:  2017-04-18       Impact factor: 4.200

Review 3.  Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance.

Authors:  Karthika Natarajan; Yi Xie; Maria R Baer; Douglas D Ross
Journal:  Biochem Pharmacol       Date:  2012-01-11       Impact factor: 5.858

4.  RNA-Seq reveals different mRNA abundance of transporters and their alternative transcript isoforms during liver development.

Authors:  Julia Yue Cui; Sumedha S Gunewardena; Byunggil Yoo; Jie Liu; Helen J Renaud; Hong Lu; Xiao-bo Zhong; Curtis D Klaassen
Journal:  Toxicol Sci       Date:  2012-03-27       Impact factor: 4.849

5.  Side population cells from HXO-Rb44 retinoblastoma cell line have cancer-initiating property.

Authors:  Jun-Jun She; Peng-Ge Zhang; Xiang-Ming Che; Xuan Wang; Zi-Ming Wang
Journal:  Int J Ophthalmol       Date:  2011-10-18       Impact factor: 1.779

6.  Functional cyclic AMP response element in the breast cancer resistance protein (BCRP/ABCG2) promoter modulates epidermal growth factor receptor pathway- or androgen withdrawal-mediated BCRP/ABCG2 transcription in human cancer cells.

Authors:  Yi Xie; Takeo Nakanishi; Karthika Natarajan; Lowell Safren; Anne W Hamburger; Arif Hussain; Douglas D Ross
Journal:  Biochim Biophys Acta       Date:  2015-01-21

7.  Epigenetic Regulation of Multidrug Resistance Protein 1 and Breast Cancer Resistance Protein Transporters by Histone Deacetylase Inhibition.

Authors:  Dahea You; Jason R Richardson; Lauren M Aleksunes
Journal:  Drug Metab Dispos       Date:  2020-03-19       Impact factor: 3.922

8.  Bcrp1 transcription in mouse testis is controlled by a promoter upstream of a novel first exon (E1U) regulated by steroidogenic factor-1.

Authors:  Yi Xie; Karthika Natarajan; Kenneth S Bauer; Takeo Nakanishi; William T Beck; Rebecca S Moreci; Pancharatnam Jeyasuria; Arif Hussain; Douglas D Ross
Journal:  Biochim Biophys Acta       Date:  2013-11-02

Review 9.  Breast cancer resistance protein (BCRP/ABCG2): its role in multidrug resistance and regulation of its gene expression.

Authors:  Takeo Nakanishi; Douglas D Ross
Journal:  Chin J Cancer       Date:  2011-11-18

10.  Methods to Discover Alternative Promoter Usage and Transcriptional Regulation of Murine Bcrp1.

Authors:  Karthika Natarajan; Yi Xie; Takeo Nakanishi; Rebecca S Moreci; Pancharatnam Jeyasuria; Arif Hussain; Douglas D Ross
Journal:  J Vis Exp       Date:  2016-05-27       Impact factor: 1.355

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.